Cargando…

The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer

Background: Gastric cancer (GC) is the third leading fatal cancer in the world and its incidence ranked second among all malignant tumors in China. The molecular classification of GC, proposed by the The Cancer Genome Atlas (TCGA), was added to the updated edition (2019) of WHO classification for di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Lei, Sun, Yeqi, Wang, Kezhou, Guan, Wenbin, Yue, Juanqing, Li, Junlei, Wang, Ruifen, Wang, Lifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399340/ https://www.ncbi.nlm.nih.gov/pubmed/32850385 http://dx.doi.org/10.3389/fonc.2020.01269

Ejemplares similares

Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer
por: Sun, Yeqi, et al.
Publicado: (2019)

Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT
por: Wang, Ruifen, et al.
Publicado: (2019)

Comparing DESI-MSI and MALDI-MSI Mediated Spatial Metabolomics and Their Applications in Cancer Studies
por: He, Michelle Junyi, et al.
Publicado: (2022)

BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway
por: Jin, Qianya, et al.
Publicado: (2022)

Prognostic Significance of Signet Ring Cells in Gastric Cancer: The Higher Proportion, The Better Survival
por: Li, Yang, et al.
Publicado: (2021)

Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy
por: Wu, Hui, et al.
Publicado: (2023)

Embryonal tumors with multilayered rosettes, C19MC-altered or not elsewhere classified: Clinicopathological characteristics, prognostic factors, and outcomes of 17 children from 2018 to 2022
por: Xu, Kailun, et al.
Publicado: (2022)

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
por: Varnier, Romain, et al.
Publicado: (2021)

High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
por: Mohamed, Amr, et al.
Publicado: (2021)

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume
por: Belkouchi, Younes, et al.
Publicado: (2022)

The Intratumor Microbiota Signatures Associate With Subtype, Tumor Stage, and Survival Status of Esophageal Carcinoma
por: Wang, Yangyang, et al.
Publicado: (2021)

Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysis
por: Jiang, Lin, et al.
Publicado: (2022)

EBV and MSI Status in Gastric Cancer: Does It Matter?
por: do Nascimento, Catarina Neto, et al.
Publicado: (2022)

Survival nomogram for different grades of gastric cancer patients based on SEER database and external validation cohort
por: Hu, Lei, et al.
Publicado: (2022)

Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
por: Oliveira, André F., et al.
Publicado: (2019)

Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer
por: Zhang, Jie, et al.
Publicado: (2023)

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China
por: Gou, Miaomiao, et al.
Publicado: (2022)

The Mechanisms Leading to Distinct Responses to PD-1/PD-L1 Blockades in Colorectal Cancers With Different MSI Statuses
por: Cui, Guanglin
Publicado: (2021)

Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2022)

Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer
por: Bao, Bowen, et al.
Publicado: (2019)

Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004)

Integration of the Tumor Mutational Burden and Tumor Heterogeneity Identify an Immunological Subtype of Melanoma With Favorable Survival
por: Gao, Yanmei, et al.
Publicado: (2020)

A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine
por: Chen, Tao, et al.
Publicado: (2019)

Importance of Examined Lymph Node Number in Accurate Staging and Enhanced Survival in Resected Gastric Adenocarcinoma—The More, the Better? A Cohort Study of 8,696 Cases From the US and China, 2010–2016
por: Huang, Lei, et al.
Publicado: (2021)

Family history of cancer is a prognostic factor for better survival in operable esophageal squamous cell carcinoma: A propensity score matching analysis
por: Zhang, Shuishen, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development
por: Li, Ruo Qi, et al.
Publicado: (2022)

Downregulation of SOX2-OT Prevents Hepatocellular Carcinoma Progression Through miR-143-3p/MSI2
por: Zhao, Hongfeng, et al.
Publicado: (2021)

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2023)

Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer
por: Zhang, Lei, et al.
Publicado: (2023)

Effect of multimodal chemotherapy on survival of gastric cancer with liver metastasis – a population based analysis
por: Li, Xinghui, et al.
Publicado: (2023)

Clinical Impact of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Stage II/III Gastric Cancer: Can We Do Better?
por: Chen, Qi-Yue, et al.
Publicado: (2020)

Leukemia With TCF3-ZNF384 Rearrangement as a Distinct Subtype of Disease With Distinct Treatments: Perspectives From A Case Report and Literature Review
por: Lin, Na, et al.
Publicado: (2021)

Case Report: MR-LINAC-guided adaptive radiotherapy for gastric cancer
por: Song, Yajun, et al.
Publicado: (2023)

The Effect of Inflammatory Markers on the Survival of Advanced Gastric Cancer Patients Who Underwent Anti-Programmed Death 1 Therapy
por: Qu, Ziting, et al.
Publicado: (2022)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2020)

LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability
por: Zhu, Yiran, et al.
Publicado: (2022)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

The Value of Whole-Tumor Histogram and Texture Analysis Using Intravoxel Incoherent Motion in Differentiating Pathologic Subtypes of Locally Advanced Gastric Cancer
por: Li, Huan-Huan, et al.
Publicado: (2022)

Impact of frailty on survival and readmission in patients with gastric cancer undergoing gastrectomy: A meta-analysis
por: Wang, Xiaoyan, et al.
Publicado: (2022)

The combination of baseline neutrophil to lymphocyte ratio and dynamic changes during treatment can better predict the survival of osteosarcoma patients
por: Li, Longqing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_imhck4uhpcuuu0blumm7fogabl